You just read:

TypeZero Technologies' Artificial Pancreas Solution, inControl AP, Will Be Tested in a Large Scale, NIH Funded ($12.7 Million) Clinical Study Run by the University of Virginia and 8 Other Locations in 2016

News provided by

TypeZero

Jan 04, 2016, 17:44 ET